News &amp; Updates

Stopping beta-blockers after a year of regular use does not appear to increase the risk of adverse clinical outcomes in myocardial infarction (MI) survivors without evidence of left ventricular systolic dysfunction or heart failure (HF), as shown in the SMART-DECISION trial.

SMART-DECISION: Stable post-MI patients can be safely taken off beta-blockers after 1 year

MetS risk higher in children with primary hypertension

Children with hypertension, particularly those with primary hypertension, are vulnerable to developing metabolic syndrome (MetS), reveals a study.

MetS risk higher in children with primary hypertension

Silymarin plus lifestyle change improves liver health in NAFLD patients with MetS

Silymarin therapy combined with lifestyle interventions can reduce and normalize liver enzyme levels in patients with nonalcoholic fatty liver disease (NAFLD) and associated metabolic syndrome (MetS), a recent study has shown.

Silymarin plus lifestyle change improves liver health in NAFLD patients with MetS

16 Apr 2026

ICLAD predicts poor vascular outcomes after ischaemic stroke

The presence of intracranial large artery disease (ICLAD) is associated with poor composite vascular outcomes, myocardial infarction (MI), and vascular death, but not recurrence, in patients with acute ischaemic stroke, suggests a Singapore study.

ICLAD predicts poor vascular outcomes after ischaemic stroke

16 Apr 2026

Novel lithotripsy device fares well in PINNACLE-I trial

The PINNACLE-I trial shows the feasibility, safety, and efficacy of LithiX, a novel Hertz contact intravascular lithotripsy (HC-IVL) device, for the treatment of calcified coronary artery lesions.

Novel lithotripsy device fares well in PINNACLE-I trial

Testosterone therapy helps alleviate menopause symptoms in breast cancer survivors

In perimenopausal and postmenopausal women with a history of breast cancer, testosterone therapy appears to yield substantial improvements in menopause symptoms, as shown in a small retrospective study.

Testosterone therapy helps alleviate menopause symptoms in breast cancer survivors

Hydroxychloroquine treatment does not prevent RA onset in at-risk individuals

In individuals at risk of rheumatoid arthritis (RA), 12 months of treatment with hydroxychloroquine falls short of preventing the development of the disease, according to the results of a phase II trial.

Hydroxychloroquine treatment does not prevent RA onset in at-risk individuals

Low micronutrients worsen effects of blood heavy metals on cognitive function

Blood concentrations of heavy metals tend to induce cognitive decline, especially among individuals with lower micronutrient status, reveals a study.

Low micronutrients worsen effects of blood heavy metals on cognitive function

DASH diet, sodium reduction improve BP levels, but not BPV

Both the Dietary Approaches to Stop Hypertension (DASH) diet and sodium intake reduction are effective in lowering absolute blood pressure (BP) levels, but these interventions do not yield significant benefits in BP variability (BPV), reports a study.

DASH diet, sodium reduction improve BP levels, but not BPV